Bavarian Nordic — Juni 2022
-
Tak Cubinvest2021, godt med de dugfriske smittetal
-
https://www.monkeypoxmeter.com/ (gengivet fra Cubinvest2021)
-
Forskellen mellem Bavarians vaccine og konkurrenten (ACAM2000): ACAM2000 is administered as a live Vaccinia virus preparation that is inoculated into the skin by pricking the skin surface. Following a successful inoculation, a lesion will develop at the site of the vaccination (i.e., a “take”). The virus growing at the site of this inoculation lesion can be spread to other parts of the body or even to other people. Individuals who receive vaccination with ACAM2000 must take precautions to
-
prevent the spread of the vaccine virus and are considered vaccinated within 28 days.
-
JYNNEOSTM is administered as a live virus that is non-replicating. It is administered as two subcutaneous injections four weeks apart. There is no visible “take” and as a result, no risk for spread to other parts of the body or other people. People who receive JYNNEOS TM are not considered vaccinated until 2 weeks after they receive the second dose of the vaccine.
-
Bmærk, at ACAM2000 medfører en "inoculation lesion" (podningslæsion), hvilket Jynneos ikke gør
-
Plus, at der ikke er risiko for at virus spredes i ens egen krop eller andre mennesker
efter at være blevet vaccineret -
ja ikke meget argument for den Amerikanske, udover den formentlig er billigere...
-
Jeg har lige skrevet følgende til Rolf (håber, at han svarer): Kan I fortælle, hvornår I regner med en evt. (haste) godkendelse fra EMA ift. brug af IMVAMUNE i Europa?
Skal denne godkendelse ligge forud for en evt. kontraktindgåelse med EU ifm. fælles opkøb af vaccinedoser?
-
Lader til at Hong Kong køber vacciner - https://www.thestandard.com.hk/section-news/section/47418371/242296/Order's-in-for-monkeypox-vaccine-as-worries-mount
-
Jynneos står nævnt på sundhedsministeriets hjemmeside i landet https://www.c
hp.gov.hk/en/healthtopics/content/24/101721.html -
fedt..kan være opjusteringen kommer idag...og stigning...men gælder alt biotek medico...så nok ikke lækket info eller noget
-
Her wiki-artiklen med de autoritative smittetal https://en.wikipedia.org/wiki/2022_monkeypox_outbreak
-
Er I opmærksomme på, at man (gratis) kan abonnere på selskabsmeddelelser vedrørende BAVA (eller andre selskaber selvfølgelig) på FT's hjemmeside? Har fx her til formiddag fået besked om, at Balyasny nu har en kort position på 0,74 % - https://oam.finanstilsynet.dk/#!/announcement-details?
Id=DFSAAnnouncement%2F88e5d486-8582-4221-bd56-aea900a12094 -
-
Tak for tippet!
-
kl. 13.00 "Another NYC Monkeypox Case Brings Total to 5, WHO Says Might Be ‘Too Late to Contain'" https://www.nbcnewyork.com/news/local/another-nyc-monkeypox-case-brings-total-to-5-who-says-might-be-too-late-to-contain/3718560/
-
Svar fra Rolf Sass Sørensen i forlængelse af mine spørgsmål (11:14): Der er forhandlinger i gang med EMA desangående. Og nej en sådan godkendelse er ingen betingelse for nogen kontrakter.
Mvh
Rolf -
det lyder satme godt...
-
og tak for info
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind